In this study, we analyzed several common polymorphisms of FGFR4 in 346 Chinese men with clinically localized prostate cancer and investigated the prognostic role of these genetic variants in biochemical recurrence (BCR) after radical prostatectomy. The gene discussed is FGFR4; the disease is prostate cancer.